Page last updated: 2024-10-29
avapro and Pyrexia
avapro has been researched along with Pyrexia in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Constable, S | 1 |
| Farrell, J | 1 |
| Naisbitt, D | 1 |
| King, C | 1 |
| Leonard, N | 1 |
| Pirmohamed, M | 1 |
Other Studies
1 other study available for avapro and Pyrexia
| Article | Year |
|---|---|
Systemic illness with skin eruption, fever and positive lymphocyte transformation test in a patient on irbesartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Eruptions; Drug Hypersensiti | 2006 |